Ravi Nistala

A reliable and efficient method for deleting operational sequences in PACs and BACs.

Differential expression of the closely linked KISS1, REN, and FLJ10761 genes in transgenic mice.

Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells.

Skeletal muscle insulin resistance is fundamental to the cardiometabolic syndrome.

Insulin resistance, oxidative stress, and podocyte injury: role of rosuvastatin modulation of filtration barrier injury.

Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment.

Redox control of renal function and hypertension.

Renin-angiotensin-aldosterone system-mediated redox effects in chronic kidney disease.

Angiotensin receptor blockers for the reduction of proteinuria in diabetic patients with overt nephropathy: results from the AMADEO study.

Dual renin-angiotensin system blockade in the ONTARGET study: clinically relevant risk for the kidney?

Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.

Intraperitoneal drug therapy: an advantage.

Bioabsorbable coronary stents--are these the next big thing in coronary angioplasty?

Stenting renal artery stenosis: what is the fuss all about?

Is there a future for direct renin inhibitors?

Micro vs. macrovascular reactivity in insulin resistance: the debate reignited.

The emerging role of biomarkers in diabetic and hypertensive chronic kidney disease.

Resistant hypertension in the high-risk metabolic patient.

Chronic kidney disease as a cardiovascular risk state and considerations for the use of statins.

The importance of early identification of chronic kidney disease.

Angiotensin II activation of mTOR results in tubulointerstitial fibrosis through loss of N-cadherin.

Prenatal Programming and Epigenetics in the Genesis of the Cardiorenal Syndrome.

Update on the role of rituximab in kidney diseases and transplant.

Mineralocorticoid receptor-dependent proximal tubule injury is mediated by a redox-sensitive mTOR/S6K1 pathway.

Over-nutrition contributes to tubulointerstitial fibrosis by targeting nutrient-sensing kinases: role for the mTOR/S6K pathway.

Combination of direct renin inhibition with angiotensin type 1 receptor blockade improves aldosterone but does not improve kidney injury in the transgenic Ren2 rat.

Anemia and chronic kidney disease: making sense of the recent trials.

Gestational Diabetes and the Offspring: Implications in the Development of the Cardiorenal Metabolic Syndrome in Offspring.

Hypertension: Synergy of antihypertensives in elderly patients with CKD.

Angiotensin type 1 receptor resistance to blockade in the opossum proximal tubule cell due to variations in the binding pocket.

Resistance to insulin and kidney disease in the cardiorenal metabolic syndrome; role for angiotensin II.

Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats.

DPP-4 Inhibitors as Therapeutic Modulators of Immune Cell Function and Associated Cardiovascular and Renal Insulin Resistance in Obesity and Diabetes.

The role of tissue Renin-Angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness.

Is there a role for the incretin system in blood pressure regulation?

Tissue-specific expression of GLP1R in mice: is the problem of antibody nonspecificity solved?

Prevention of obesity-induced renal injury in male mice by DPP4 inhibition.

DPP4 inhibition attenuates filtration barrier injury and oxidant stress in the zucker obese rat.

Dipeptidyl peptidase-4 inhibition ameliorates Western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic mitochondrial function.

Mineralocorticoid receptor blockade prevents Western diet-induced diastolic dysfunction in female mice.

Angiotensin II Stimulation of DPP4 Activity Regulates Megalin in the Proximal Tubules.